4//SEC Filing
KOS PHARMACEUTICALS INC 4
Accession 0001018952-05-000056
CIK 0001018952operating
Filed
Jun 5, 8:00 PM ET
Accepted
Jun 6, 5:03 PM ET
Size
9.1 KB
Accession
0001018952-05-000056
Insider Transaction Report
Form 4
BALDINI ROBERT E
Director
Transactions
- Sale
Common Stock, $.01 Par Value
2005-06-03$58.68/sh−10,000$586,800→ 6,524 total - Exercise/Conversion
Common Stock, $.01 Par Value
2005-06-03$22.55/sh+10,000$225,500→ 16,524 total - Exercise/Conversion
Stock Option (Right to Buy)
2005-06-03−10,000→ 40,000 totalExercise: $22.55Exp: 2012-01-29→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]One share owned jointly with spouse.
- [F2]Includes 6,523 shares of Kos common stock acquired by reporting person in transactions exempt under Section 16 of the Exchange Act under the Kos 401(k) Plan and the Employee Stock Purchase Plan.
- [F3]Part of an original grant of 50,000 options, exercisable in the following amounts on the following exercise dates: 12,500 on January 30, 2003 12,500 on January 30, 2004 12,500 on January 30, 2005 12,500 on January 30, 2006
Documents
Issuer
KOS PHARMACEUTICALS INC
CIK 0001018952
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001018952
Filing Metadata
- Form type
- 4
- Filed
- Jun 5, 8:00 PM ET
- Accepted
- Jun 6, 5:03 PM ET
- Size
- 9.1 KB